Impax Laboratories Settles Pending Litigation for FLOMAX(R)
Impax Laboratories Receives Tentative FDA Approval for Generic FLOMAX(R) 0.4mg Capsules
Data from a head-to-head crossover study evaluating FOSRENOL
Fresenius Medical Care introduces programme for improved PD therapy